Yifan Xinfu Pharmaceutical Co Ltd Net Asset Quality Index
Yifan Xinfu Pharmaceutical Co Ltd net asset quality index. Yifan Xinfu Pharmaceutical Co Ltd (002019) has a Net Asset Quality Index of 68.2% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥12.85 Billion minus total liabilities of CN¥4.08 Billion yields net assets of CN¥8.76 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See 002019 total equity for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Yifan Xinfu Pharmaceutical Co Ltd (2001–2025)
Net asset quality index of Yifan Xinfu Pharmaceutical Co Ltd from 2001 to 2025. This chart shows how Yifan Xinfu Pharmaceutical Co Ltd's Net Asset Quality Index has evolved across 25 annual periods from 2001 to 2025. As of March 2026, the index stands at 68.2%, representing net assets of CN¥8.76 Billion against total assets of CN¥12.85 Billion CNY. Check Yifan Xinfu Pharmaceutical Co Ltd (002019) strategic asset index to assess the company's strategic physical and investment asset allocation.
Yifan Xinfu Pharmaceutical Co Ltd Net Asset Quality Index by Year (2001–2025)
Yifan Xinfu Pharmaceutical Co Ltd net asset quality index by year from 2001 to 2025. The table below presents the year-by-year Net Asset Quality Index for Yifan Xinfu Pharmaceutical Co Ltd from 2001 to 2025, covering 25 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Yifan Xinfu Pharmaceutical Co Ltd (002019) total market value.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 67.8% | CN¥8.71 Billion | CN¥12.85 Billion | CN¥4.13 Billion | ▼ -0.8 pp |
| 2024 | 68.6% | CN¥8.43 Billion | CN¥12.29 Billion | CN¥3.86 Billion | ▼ -3.2 pp |
| 2023 | 71.8% | CN¥8.25 Billion | CN¥11.50 Billion | CN¥3.24 Billion | ▼ -1.1 pp |
| 2022 | 72.9% | CN¥9.15 Billion | CN¥12.54 Billion | CN¥3.40 Billion | ▲ +0.8 pp |
| 2021 | 72.1% | CN¥8.78 Billion | CN¥12.17 Billion | CN¥3.39 Billion | ▼ -2.3 pp |
| 2020 | 74.5% | CN¥8.72 Billion | CN¥11.71 Billion | CN¥2.99 Billion | ▲ +3.8 pp |
| 2019 | 70.7% | CN¥7.82 Billion | CN¥11.07 Billion | CN¥3.24 Billion | ▲ +0.2 pp |
| 2018 | 70.5% | CN¥6.89 Billion | CN¥9.77 Billion | CN¥2.89 Billion | ▼ -6.9 pp |
| 2017 | 77.4% | CN¥6.78 Billion | CN¥8.77 Billion | CN¥1.99 Billion | ▲ +21.5 pp |
| 2016 | 55.9% | CN¥3.90 Billion | CN¥6.98 Billion | CN¥3.08 Billion | ▼ -7.5 pp |
| 2015 | 63.4% | CN¥2.88 Billion | CN¥4.55 Billion | CN¥1.67 Billion | ▼ -12.9 pp |
| 2014 | 76.3% | CN¥2.54 Billion | CN¥3.33 Billion | CN¥791.21 Million | ▲ +19.1 pp |
| 2013 | 57.2% | CN¥384.95 Million | CN¥673.14 Million | CN¥288.20 Million | ▲ +11.9 pp |
| 2012 | 45.3% | CN¥480.81 Million | CN¥1.06 Billion | CN¥580.73 Million | ▲ +5.0 pp |
| 2011 | 40.3% | CN¥469.52 Million | CN¥1.17 Billion | CN¥696.73 Million | ▼ -18.3 pp |
| 2010 | 58.6% | CN¥703.64 Million | CN¥1.20 Billion | CN¥497.79 Million | ▼ -21.5 pp |
| 2009 | 80.1% | CN¥913.15 Million | CN¥1.14 Billion | CN¥227.31 Million | ▲ +13.4 pp |
| 2008 | 66.7% | CN¥570.87 Million | CN¥856.27 Million | CN¥285.39 Million | ▲ +4.6 pp |
| 2007 | 62.0% | CN¥548.55 Million | CN¥884.42 Million | CN¥335.87 Million | ▲ +7.3 pp |
| 2006 | 54.8% | CN¥324.46 Million | CN¥592.38 Million | CN¥267.92 Million | ▼ -7.3 pp |
| 2005 | 62.1% | CN¥320.93 Million | CN¥516.94 Million | CN¥196.02 Million | ▼ -24.3 pp |
| 2004 | 86.4% | CN¥309.98 Million | CN¥358.70 Million | CN¥48.72 Million | ▲ +39.0 pp |
| 2003 | 47.4% | CN¥94.31 Million | CN¥199.04 Million | CN¥104.73 Million | ▼ -12.8 pp |
| 2002 | 60.2% | CN¥79.43 Million | CN¥131.96 Million | CN¥52.53 Million | ▲ +0.3 pp |
| 2001 | 59.9% | CN¥52.31 Million | CN¥87.37 Million | CN¥35.05 Million | — |